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ABSTRACT  The pressure-temperature phase diagram of morniflumate (niflumic acid β-morpholinoethyl ester) has been obtained by high-pressure thermal analysis. In addition, calorimetric melting data (TI→L = 348.1 ±0.4 K and ∆HI→L = 89 ±2 J g-1) and the specific volumes of the solid and the liquid state have been obtained under normal pressure. Comparison of the measured high-pressure melting data with the equilibrium curve obtained through the Clapeyron equation indicates that the initial slopes are the same (dP/dT = 2.96 ±0.06 MPa K-1) at the melting point under normal pressure. The fact that the Clapeyron equation can be used to construct topological phase diagrams may be of interest for the food and pharmaceutical industries.  
Keywords: high-pressure, pressure-temperature phase diagram, Clapeyron, topological phase diagram, specific volume, density   
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1 INTRODUCTION  Unary pressure-temperature phase diagrams are used in physical chemistry for more than a hundred years and were a popular subject of research at the end of the nineteenth century and the beginning of the twentieth century as can be judged by the contributions from Tammann, Hulett, Bakhuis-Roozeboom, and Bridgman [1-4]. In the meantime, high-pressure research has moved on to ultra-high pressures, even if high-pressure research of molecular substances is important for the understanding of their solid-state behavior. Crystalline polymorphism is an issue in the pharmaceutical and food industry and depends on the thermodynamics of the system. High-pressure measurements can give access to thermodynamic quantities, such as transition temperature, transition enthalpy, and volume change in the system through the Clapeyron equation:           (1)  
with ∆s the specific entropy change associated with the phase transition, ∆v the specific 
volume change, ∆h the specific enthalpy change and T the equilibrium temperature (as 
T·∆s = ∆h is valid at equilibrium). On the one hand, such measurements make it possible to verify enthalpy and specific volume values obtained by calorimetry and X-ray diffraction under ambient pressure conditions, and on the other hand, the Clapeyron equation can be used to calculate the high-pressure behavior of the system [5, 6]. This is in particular interesting for the pharmaceutical industry, when they need to decide to what extent polymorphism may cause problems in the preformulation stage of a drug. However, little is known about the extent the dP/dT slope obtained through the Clapeyron equation can be extrapolated to higher pressure, because few phase diagrams on molecular compounds and active pharmaceutical compounds (APIs) exist. Thus from a practical standpoint, high-pressure phase diagram research reinforces an easy access to the thermodynamic behavior of small molecular compounds, which is directly applicable in industry and from a more academic standpoint, high-pressure data provides inside in general thermodynamic properties such as the specific volume (equation of state) and the entropy of molecular systems under pressure. More experimental data will definitely support the theoretical inroads made to describe the solid and liquid state of molecular substances. The anti-inflammatory API morniflumate is the β-morpholinoethyl ester of niflumic acid. According to patent EP0349902A2, it “was described for the first time by C. 
Hoffmann in French Patent n° 7963M filed on october 1968” [7]. Esterification of niflumic acid with the β-morpholinoethyl moiety was intended to improve drug tolerability and to reduce injuries of the gastrointestinal mucosa. Solid-state studies indicated that the compound crystallizes in a triclinic structure, which was solved by Toffoli et al in 1988 [8]. The molecular structure based on the crystal structure has been provided in Figure 1. The thermodynamic properties such as the melting temperature, heat of fusion and the specific heat have been investigated by Pinvidic et al. in 1989 [9]. In this paper, the pressure-temperature (P-T) phase diagram of morniflumate is presented and used to investigate the difference between the experimental slope and the slope as determined by the Clapeyron equation. In addition, the required thermodynamic data, such as the melting temperature, the melting enthalpy, and the specific volume of the solid and the liquid will be discussed. 
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2 EXPERIMENTAL  
2.1 Sample Morniflumate (Figure 1) of medicinal grade, manufactured by Archimica SAS, France, obtained from UPSA laboratories was used as provided after verification by X-ray and DSC. The certificate of analysis from Archimica SAS indicated a purity higher than 99% with a content in free niflumic acid of 0.1% (m/m).   
2.2 Differential Scanning Calorimetry (DSC) Temperature (onset) and heat of fusion were obtained with two Q100 thermal analyzers from TA Instruments at different sites with various heating rates. The analyzers were calibrated by using the melting point of indium (Tfus = 429.75 K and ∆fusH = 3.267 kJ mol-1). Specimens were weighed using a microbalance sensitive to 0.01 mg and for the second DSC sensitive to 0.001 mg and sealed in aluminum pans.  
2.3 High-resolution X-ray powder diffraction Two series of XRPD measurements using the Debye–Scherrer geometry and transmission mode were performed with a vertically mounted INEL cylindrical position-sensitive detector (CPS-120). Monochromatic Cu-Kα1 (λ = 0.154056 nm) radiation was selected by means of an asymmetrically focusing incident-beam curved quartz monochromator. Measurements as a function of temperature were performed using a liquid nitrogen 700 series Cryostream Cooler from Oxford Cryosystems. Cubic phase Na2Ca3Al2F4 was used for external calibration. PEAKOC application from DIFFRACTINEL software was used for the calibration as well as for the peak position determinations after pseudo-Voigt fittings and lattice parameters were refined by way of the least-squares option of the FullProf suite [10, 11]. Specimens were introduced in a Lindemann capillary (0.5-mm diameter) and allowed to rotate perpendicularly to the X-ray beam during the experiments to improve the averaging of the crystallite orientations. Before each isothermal data acquisition the specimen was allowed to equilibrate for about 10 min, and each acquisition time was no less than 1 h. The heating rate in-between data collection was 1.33 K min-1. Patterns were recorded on heating in the temperature range from 100 K up to the melting point. 
 
2.4 Densitometry of the melt as a function of temperature Liquid density as a function of temperature was measured with a DMA-5000 Density Meter from Anton-Paar. The specimen was introduced in the molten state in the apparatus equilibrated at a temperature above the temperature of fusion. Data were obtained at isothermal steps while slowly cooling in the temperature range from 363 to 323 K. Dry air and bi-distilled water were used as calibration standards in the temperature range. The temperature was controlled at ± 1 mK.  
2.5 High-pressure differential thermal analysis (HP-DTA) HP-DTA measurements have been carried out at 2 K min-1 using a home-made high-pressure differential thermal analyzer similar to Würflinger’s apparatus and operating in the 298 – 473 K and 0 – 250 MPa ranges [12]. To determine the melting temperature as a function of pressure and to ascertain that in-pan volumes were free from residual air, specimens were mixed with an inert perfluorinated liquid (Galden®, from Bioblock Scientifics, Illkirch, France) as a pressure-transmitting medium, and the mixtures were sealed into cylindrical tin pans. To check that the perfluorinated liquid was chemically 
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inactive, and should thus have no influence on the melting temperature of morniflumate, preliminary DSC measurements were carried out with a Galden®-morniflumate mixture on a Q100 analyzer of TA instruments without applied pressure.  
3 RESULTS  
3.1 Calorimetric data DSC measurements have been carried out with thirteen different samples using heating rates of 0.5, 2, 5, and 10 K min-1. The results of the individual measurements have been compiled in Table S1 in the Supplementary Materials. It has led to a temperature of fusion, TI→L, of 348.1 K ±0.4 K (standard uncertainty u) obtained from the onset of the melting peak and it has yielded the mean value of 89.4 J g-1 ±1.6 J g-1 (u) 
for the melting enthalpy, ∆HI→L, a little larger than the value of 87.25 J g-1 found previously [9]. Neither the melting point nor the melting enthalpy appear to depend on the heating rate of the DSC. On reheating the melt, a glass transition was observed in agreement with previous findings [9] at Tg = 249.4 K ±0.5 K (u) (midpoint) and no further recrystallization is observed. In Figure 2, the melting peak and the glass transition for the heating rate of 2 K min-1 has been provided.  
3.2 Specific volume as a function of temperature  
3.2.1 Crystalline morniflumate Two different samples of morniflumate have been measured with X-ray powder diffraction and the lattice parameters as a function of temperature have been calculated. They can be found in the Supplementary Materials Table S2. The resulting unit cell volumes and specific volumes of morniflumate as a function of the temperature have been compiled in Table 1. The specific volumes of the crystalline solid, which have been plotted in Figure 3 were fitted to a quadratic function  (vs /cm3g-1, T /K, ±u):  
vs (T) = 0.6778 (±0.0011) + 5.8 (±1.0) × 10-5 T + 1.7 (±0.2) × 10-7 T2 (r2 = 0.999) (2)  
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Table 1. Morniflumate unit cell volume (Vcell), which contains two molecules (Z = 
2), and specific volume (vs) as a function of temperature (T) measured in an open 
system under air with a pressure of 0.1 MPa.a 
T /K Vcell /10-3 nm3 vs /cm3 g-1 First series 100.0 900.4 0.68570 150.0 907.6 0.69118 200.0 915.01 0.69682 320.0 938.2 0.71445 330.0 939.6 0.71558 335.0 941.6 0.71705 340.0 942.4 0.71766 Second series 125.0 902.4 0.68720 175.0 910.01 0.69301 225.0 918.60 0.69955 250.0 923.82 0.70353 273.0 927.45 0.70630 298.2 934.34 0.71154 315.0 936.85 0.71346 325.0 938.50 0.71471 332.0 940.94 0.71657 337.0 941.6 0.71711 342.0 943.34 0.71840 347.0 944.39 0.71920 aStandard uncertainties are u(T) = 0.2 K, ur(P) = 0.05, u(Vcell) = 0.55 ×10-3 nm3 and u(vs) = 0.0004 cm3g-1.   
3.2.2 Liquid morniflumate The density of molten morniflumate was measured with decreasing temperature every five kelvins from 363 K to 323 K. Results have been compiled in Table S3 in the Supplementary Materials and a linear fit to the temperature dependent specific volume (vliq/cm3g-1, T /K, ±u) has led to:  
vliq(T) = 0.6045 (±0.0005) + 0.000579 (±0.000014) × T  (r2 = 0.9999)  (3)  The specific volume of the liquid has been plotted in Figure 3 together with the data for the crystalline state. 
 
3.3 High-pressure differential thermal analysis The melting temperatures observed in seven runs at different pressures ranging from 0 to 250 MPa have been compiled in Table 2. The resulting pressure-temperature melting curve based on the “raw” unrounded data, using T as the running variable and giving P as a function of T, is best described by a straight line (with P in MPa and T in K, ±u):  
P = –1201 (±40) + 3.44 (±0.11) T     (R2 = 0.994)  (4) 
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Table 2. Pressures (P) and onset temperatures (T) of the melting peaks obtained 
by high-pressure differential thermal analysis.a 
P /MPa T /K 0.1 348.1 32 358.5 58 366.9 79 374.5 115 382.7 140 390.7 155 396.0 201 403.7 244 421.5 aStandard uncertainties are u(T) = 0.4 K and ur(P) = 0.05 for P = 0.1 MPa and u(T) = 1.5 K and u(P) = 1 MPa for P > 0.1 MPa.  
 
4 DISCUSSION 
 
4.1 The thermal expansion of the solid and the liquid The thermal expansion of the volume of solid morniflumate is best fitted by the quadratic expression eq. 2. However, to compare its expansion with other molecular solids, it is more convenient to determine the thermal expansion coefficient αV,s, which is defined by the linear equation vs(T) = v0 (1+αV,s T). Fitting the data in Table 1 to the latter equation, leads to 2.09 (±0.04) ×10–4 K–1 for αV,s (with v0 = 0.6695(±0.0008) cm3g-1) in the temperature range of 100 to 347 K. This is very close to the value of 2.21 ×10-4 K-1 previously reported by the present authors for solid molecular active ingredients, which had also been reported by Gavezzotti for solid organic compounds [13-15]. Clearly, morniflumate has a very predictable average thermal expansion in the solid state.  Molten morniflumate has a thermal expansion described by the linear equation 3. Using the same approach to obtain the thermal expansion coefficient of the liquid phase 
αV,liq, 9.58(±0.24) ×10–4 is found, which is somewhat smaller than 1.20(±0.25) ×10–3 K–1 found previously for similar compounds, but it is still within the standard deviation of the observed distribution for the thermal expansion of liquids of active pharmaceutical compounds [14, 15]. 
 
4.2 Isobaric thermal expansion tensor for the solid The anisotropy of the intermolecular interactions can be investigated with the isobaric thermal expansion tensor, which is a measure of how the interactions change with temperature [16]. It is the symmetrical second-rank tensor, with nonzero 
eigenvalues on the diagonal α1, α2, and α3 [17-23]. A small value for a tensor eigenvalue is commonly referred to as a “hard” direction indicating a small deformation and a large value as a “soft” direction indicating a large deformation. For triclinic systems, the eigenvectors are completely independent of the crystal axes a, b, and c and contrary to them, the eigenvectors constitute an orthogonal system. With the thermal expansion data provided in the Supplementary Materials (Table S2), the isobaric thermal expansion tensor has been calculated. The full results can be found in Table S4 of the Supplementary Materials and a graphic representation of the tensor at 255 K can be found in Figure 4. The eigenvalues increase with the temperature, but are under all circumstances positive. At 300 K, the soft direction of the crystal is 
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characterized by α1 with a value of 1.53 ×10-4 and the hardest direction by α3 with a value of 0.21 ×10-4. The intermediate α2 has a value of 0.54 ×10-4. The aspherism coefficient (symbol A in Table S4 in the supplementary materials) indicative for the measure of anisotropy in the thermal expansion is in the order of 0.4 (see also the graphical representation of the tensor in Figure 4), but it tends to become smaller with increasing temperature, indicating that the expansion becomes more isotropic (A = 0 representing fully isotropic expansion). The eigenvalues of the tensor are comparable to those of other small organic compounds with therapeutic activity, like L-tyrosine methyl ester, L-tyrosine ethyl ester, and tienoxolol for example [21, 24, 25]. Due to a lack of classical hydrogen bond donors—the only N-H present in the structure is involved in an intramolecular hydrogen bond—the crystal is susceptible to thermal expansion in all directions and in particular the expansion of the hard direction is relatively large in comparison with the examples mentioned just above. On the other hand, it is clear that the soft direction, α1, is marked by layers of morniflumate molecules that share few close contacts (This has been illustrated in the Supplementary Materials in Figure S1). It may be one of the main causes of the relatively low melting point of morniflumate. The other directions contain some of the weaker types of hydrogen bonds between hydrogens of the aromatic rings as donor and the double bonded oxygen of the ester as acceptor.  
4.3 The volume change on melting  On melting, the directional short-range interactions present in the crystalline materials cease to exist and are replaced by more random interactions in the liquid state. Even if the molecules remain close, the random positioning of the molecules in the liquid is in general accompanied by an increase of volume on melting (except for a few special cases such as water). In the case of small organic molecules (100 – 500 g mol-1) to which morniflumate belongs together with many other pharmaceuticals, the volume increase on melting tends to be on average about 10% ± 3% [14, 15], slightly smaller than the 12% based on 21 compounds reported previously by Goodman et al. [26].  Taking the specific volume dependence of the crystalline solid with the temperature (eq. 2) and the temperature of melting of 348.1(±0.4) K, the specific volume of the crystal at the melting temperature can be calculated to be 0.71923(±0.00042) cm3g-1. The temperature dependence for the liquid (eq. 3) leads to a specific volume at the melting point of 0.80615(±0.00007) cm3g-1. Thus, the change in specific volume on melting equals 0.08692(±0.00049) cm3g-1 and the ratio vliq/vs is 1.121(±0.001). The latter ratio is in very good agreement with the volume changes on melting mentioned above.  
4.4 The volume difference at the glass transition  The glass transition temperature was found at 249.4 K. At this temperature the undercooled liquid becomes a “solid” kinetically restrained liquid. By extrapolation of eq. 3, the specific volume of the liquid at the glass transition can be estimated and was found to be 0.7490(±0.0004) cm3 g-1. The crystalline solid at that temperature (eq. 2) has a specific volume of 0.7032(±0.0004) cm3 g-1. The glass is less dense than the crystalline phase and the difference in specific volume is 0.0458(±0.0008) cm3g-1. The ratio of the specific volume of the solid over that of the liquid is 1.065(±0.001), disregarding the 1, the decimal values of this ratio are approximately half in comparison with the ratio at the melting point. 
 9 
The specific volume of the glassy state as a function of the temperature generally levels off strongly and starts to contract like the solid state. If the contraction as observed in the liquid state were to continue, the liquid (or glass) would at a given temperature have the same density as the crystalline phase. This is called the Kauzmann paradox, as it would be impossible that a disordered liquid can have the same specific volume as the ordered crystalline solid [27]. The temperature at which this seemingly occurs is called the Kauzmann temperature, which for this system would be 148 K (see Figure 3). If a glass transition is lacking, the Kauzmann temperature can be considered the extreme minimum temperature, where a liquid phase could exist. Obviously, any experimental glass transition will occur above the Kauzmann temperature.  
4.5 The slope of the solid-liquid equilibrium in the pressure-temperature diagram  The slope of a two-phase equilibrium in a pressure-temperature phase diagram is given by the Clapeyron equation (eq. 1). Using the values obtained by calorimetric 
measurement, one finds that the entropy change, ∆s, equals 89.43/348.1 = 0.2569(±0.0047) J g-1 K-1. The slope of the melting equilibrium with the volume change calculated above leads to dP/dT = 0.2569/0.08692 = 2.96(±0.07) MPa K-1. The dP/dT slope calculated with the Clapeyron equation (eq. 1), is rather low in comparison with the experimental value obtained by the high pressure differential thermal analysis, which has led to 3.44(±0.11) MPa K-1 (eq. 4) The reason for this difference is most likely related to the curvature of the melting equilibrium, as in most cases the volume of the liquid will change more readily with increasing pressure than the solid. Therefore, the volume change on which the slope of the equilibrium depends as can be seen in the Clapeyron equation (eq. 1) will change to a certain extent with pressure. It may be possible to investigate this using a quadratic function to fit the experimental data in Table 2:  
P = –892(±695) + 1.8(±3.6) T + 2.1(±4.7) ×10–3 T2  (R2 = 0.994)  (5)  It can immediately be seen that the quadratic function does not capture the curvature of the slope, as its correlation coefficient and that of eq. 4, the linear function, are the same and thus the quadratic function does not improve the fit. Furthermore, the errors over the fitting parameters are larger than their values and they can therefore not be considered statistically sound, even if the overall fit is acceptable. Evaluating the slope at 348.1 K nonetheless, leads to a value of 3.29 MPa/K, thus slightly smaller than that found by the linear equation, however the statistical error is larger than its value and thus it is not possible to compare the slope obtained from eq. 5 with the value obtained by the Clapeyron equation. This problem is most likely due to the scatter over the measurement points, which make it difficult for the quadratic equation to capture the proper curvature. An alternative is to investigate the change of the slope by fitting a limited number of points to a straight line, starting at zero pressure and one by one adding a melting temperature obtained at a higher pressure. The resulting slopes can be found in Table 3.  
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Table 3. The evolution of the equilibrium slope with standard uncertainty u and 
its correlation coefficient R2 based on a linear equation as a function of the 
number of data points used Number of data points Slope (±u) R2 2 3.05(-)a 1a 3 3.09(±0.03) 0.99992 4 3.01(±0.05) 0.9994 5 3.25(±0.15) 0.994 6 3.30(±0.11) 0.996 9 3.44(±0.11) 0.994 Clapeyron (eq. 4) 2.96(±0.06) - a no error with only two data points   It is clear from table 3 that using only a few points to determine the slope of the equilibrium, the value is much closer to the one determined by the Clapeyron equation. As the error over the values determined with only a few points is most likely underestimated, ±0.11 MPa/K can be used as a global error, because this seems to be approximately de limiting error when all P-T data points are used. In that case, the slopes calculated with 2, 3, or 4 data points are within error equal to the value obtained by the Clapeyron equation (for example 3.01 ± 0.11 and 2.96 ± 0.7 MPa/K). So even though due to possible scatter over the experimental data points the curvature of the melting equilibrium cannot not be fitted well with a quadratic function, the foregoing analysis seems to point to a slight curvature. Further evidence that the Clapeyron equation describes the initial slope at 0 MPa well can be found in Figure 5, where the measured data points are plotted together with those obtained through the Clapeyron equation. The points obtained by the Clapeyron equation virtually overlap with the first four high-pressure data points.  
5 CONCLUDING REMARKS   The specific volume data obtained for morniflumate confirms the statistics found for the specific volume data of other small molecular compounds. The expansion coefficients in the solid and in the liquid are both close to the statistical averages. In addition, the ratio of the volume change on melting of morniflumate is found to be very close to the average range of 10 to 12 % in volume increase.  It is also clear from the experimental pressure-temperature melting curve that the Clapeyron equation using only the melting enthalpy and temperature obtained by DSC and the specific volumes obtained by X-ray and density measurements provides a good estimate of the initial slope of the melting equilibrium (see Figure 5). It is however important to be able to fit the curvature of the experimental pressure-temperature curve correctly and that may in certain cases not be easy as has been demonstrated by the case of morniflumate. Nonetheless, this paper shows that the Clapeyron equation can be reliably used to construct topological pressure-temperature phase diagrams without the immediate need of measuring systems under pressure. This may be an advantage for the food and drug industries.  
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Figure 
 
 
Figure 1. Molecular structure of morniflumate [8] C19H20F3N3O3, Mw = 395.38 g mol-1, black spheres are carbon atoms and light grey spheres are hydrogen atoms, oxygen, nitrogen and fluor atoms have been labeled in the figure.   
 
Figure 2. The melting peak and after cooling and reheating the glass transition of morniflumate as obtained by differential scanning calorimetry at a heating rate of 2 K min-1.  
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Figure 3. Temperature dependence of the specific volume of crystalline (filled circles: first sample, open circles: second sample) and molten morniflumate (filled squares). The dashed lines through the symbols represent the respective fits, eqs. 2 and 3. The light grey dashed line parallel to the specific volume of the crystalline phase represents the hypothetical specific volume of the glass phase starting at the glass transition temperature Tg ≈ 248 K. Tk is the Kauzmann temperature at which the vliq of the metastable liquid paradoxically becomes the same as that of the crystalline solid.  
  
Figure 4. Illustration of the isobaric thermal expansion tensor at 255 K  
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Figure 5. Melting curve of crystalline morniflumate as a function of temperature (T) and pressure (P). Open circles: experimental HP-DTA values, solid circles: melting data calculated with the Clapeyron equation at the same temperatures as the experimental data (eq. 1). The dotted line is a straight equilibrium line based on the Clapeyron equation. The increasing deviation of the measured data from the straight extrapolation based on the Clapeyron equation is clear, but cannot be easily captured by a second order equation (see text).  
